IOBT- Io Biotech, Inc.

Name: Io Biotech, Inc. Insider Trading Data
Creator: U.S. Securities and Exchange Commission
License: https://www.sec.gov/privacy#accessibility

Io Biotech, Inc. (IOBT) has 6 insiders with recent SEC Form 4 filings, including 8 buys and 4 sells. IOBT is classified in the Biotechnology industry within the Health Care sector.

Insider Ownership

Role	Insider	Shares	Value	30d
?	Smith David V	35.1K	$1.7K	-
?	Hunter Heidi	35.1K	$1.7K	-
?	Hirth Peter	35.1K	$1.7K	-
?	Glaub Kathleen Sereda	35.1K	$1.7K	-
?	Elling Christian E	35.1K	$1.7K	-

Activity

Buys and sells only

Transactions

10 filings

Date	Insider	Role	Type	Shares	Price	Value	Chg%	3M	12M
May 30, 2025	Hunter Heidi	-	Buy	15,000	$1.39	$20,884.50	New	+11.3%	-
Dec 23, 2024	Ahmad Qasim Iftikhar	Chief Medical Officer	Buy	31,350	$0.85	$26,553.45	New	+12.4%	-21.3%
Dec 23, 2024	Zocca Mai-Britt	Chief Executive Officer	Buy	12,500	$0.81	$10,120.00	+33.4%	+12.4%	-21.3%
Dec 23, 2024	Sullivan Amy	Chief Financial Officer	Buy	10,250	$0.83	$8,482.90	+13.8%	+12.4%	-21.3%
Dec 23, 2024	Smith Devin Whittemore	General Counsel	Buy	12,000	$0.81	$9,720.00	+243.0%	+12.4%	-21.3%
Jul 26, 2024	Novo Holdings A/s58	10% Owner	Sell	75,000	$1.32	$99,125.48	-0.9%	-5.4%	+59.7%
May 10, 2024	Novo Holdings A/s58	10% Owner	Sell	658,809	$1.22	$802,495.24	-12.9%	+0.7%	-30.1%
Feb 9, 2024	Novo Holdings A/s58	10% Owner	Sell	658,809	$1.50	$988,411.14	-11.5%	-3.1%	-41.3%
Nov 22, 2023	Burkavage Brian	Chief Accounting Officer	Buy	10,000	$1.01	$10,125.00	+125.0%	+48.6%	-35.0%
Aug 9, 2023	Novo Holdings A/s58	10% Owner	Buy	2,469,135	$2.03	$4,999,998.38	+76.2%	-45.8%	-20.0%

Page 1Next →

Insider	Role	Shares	Value	Buys	Sells

Date	Ticker	Insider	Role	Type	Shares	Price	Value	Chg%	SEC